DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20195681

Evaluation of vitamin D status, selenium and C-reactive protein level in psoriasis

S. Sumathi, S. Vinod Babu, K. Karthikeyan

Abstract


Background: Psoriasis is an inflammatory skin disease associated with a variety of clinical conditions. Study aim to evaluate the association of vitamin D, selenium and C-reactive protein (CRP) levels in psoriasis.

Methods: This hospital-based case-control study involved 50 psoriasis cases and 47 healthy individuals. Serum vitamin D, selenium and CRP levels were measured, and the general demographic values were also recorded.

Results: Statistical analysis revealed that vitamin D levels are significantly lower in psoriasis (p<0.005). Among the demographic parameters, obesity was found more common among psoriasis cases than controls. Serum selenium and CRP levels were not significantly different between the two groups.

Conclusions: Vitamin D deficiency is strongly associated with psoriasis. Vitamin D supplementation can be useful in psoriasis management and also in the reduction of obesity. Serum selenium and CRP levels aren’t significant markers to demonstrate psoriasis.


Keywords


C-reactive protein, Vitamin-D, Psoriasis, Selenium

Full Text:

PDF

References


Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. American J Clini Nutr. 2004;80(6):1717S-20S.

Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Göß C, Anz D, et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Trans Med. 2011;3(82):38.

Gisondi P, Rossini M, Di Cesare A, Idolazzi L. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166(3):505-10.

Fu LW, Vender R. Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome. Dermatol Res Pract. 2011: 1-4.

Peric M, Koglin S, Dombrowski Y, Groß K, Bradac E, Büchau A, et al. Vitamin D analogs differentially control antimicrobial peptide/“alarmin” expression in psoriasis. PloS One. 2009;4(7):e6340.

Fu LW, Vender R. Review. Systemic role for vitamin D in the treatment of psoriasis and metabolic syndrome. Derm Res Persp. 2011;2011:ID 276079.

Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Ind J Dermatol Venereol Leprol. 2010;76:662-5.

Serwin AB, Wasowicz W, Gromadzinska J, ożena Chodynicka B. Selenium status in psoriasis and its relations to the duration and severity of the disease. Nutr. 2003;19(4):301-4.

Matloob NA. Selenium Level in Lichen Planus and in Psoriasis and Its Relation to Chronicity and Severity of Both Diseases. Iraq J Med Sci. 2011;9(1):11-7.

Jain VK, Lal H. C-reactive protein and uric acid levels in patients with psoriasis. Ind J Clini Biochem. 2011;26(3):309-11.

Donadini A, Fiora C, Regazzini R, Perini D, Minoia C. Selenium plasma levels in psoriasis. Clini Experiment Dermatol. 1992;17(3):214-6.

Naziroglu M, Yildik K, Tamturk B, Erturan I, Flores-Arce M. Selenium and psoriasis. Biol Trace Elem Res. 2012;150(1-3):3-9.

Lowe KE, Norman AW. Vitamin D and psoriasis. Nutrition Rev. 1992;50(5):138-42.

Zuchi MF, Azevedo PD, Tanaka AA, Schmitt JV, Martins LE. Serum levels of 25-hydroxy vitamin D in psoriatic patients. Anais Brasileiros Dermatol. 2015;90(3):430-2.

Marques CD, Dantas AT, Fragoso TS, Duarte ÂL. The importance of vitamin D levels in autoimmune diseases. Revista Brasileira Reumatol. 2010;50(1):67-80.

Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clini Nutr. 2000;72(3):690-3.

Vanlint S. Vitamin D and obesity. Nutr. 2013;5(3):949-56.

Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diab. 2012;2(12):e54.

Al-Jebori AA. Serum Selenium in Psoriatic Patients. Iraqi J Commu Med. 2007;20(3):409-13.

Serwin AB, Chodynicka B, Wasowicz W, Gromadzińska J. Selenium nutritional status and the course of psoriasis. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego. 1999;6(35):263-5.

Vadakayil AR, Dandekeri S, Kambil SM, Ali NM. Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis. Ind Dermatol Online J. 2015;6(5):322-5.

Farshchian M, Ansar A, Sobhan M, Hoseinpoor V. C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B. Anais Brasileiros Dermatologia. 2016;91(5):580-3.

Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, et al. Effects of etanercept on C‐reactive protein levels in psoriasis and psoriatic arthritis. Brit J Dermatol. 2008;159(2):322-30.

Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. C‐reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Euro Acad Dermatol Venereol. 2010;24(7):789-96